Sayers M - Search Results

1

Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation.

Bowden RA, Sayers M, Flournoy N, Newton B, Banaji M, Thomas ED, Meyers JD. Bowden RA, et al. Among authors: sayers m. N Engl J Med. 1986 Apr 17;314(16):1006-10. doi: 10.1056/NEJM198604173141602. N Engl J Med. 1986. PMID: 3007984 Clinical Trial.

2

Cytomegalovirus-seronegative blood components for the prevention of primary cytomegalovirus infection after marrow transplantation. Considerations for blood banks.

Bowden RA, Sayers M, Gleaves CA, Banaji M, Newton B, Meyers JD. Bowden RA, et al. Among authors: sayers m. Transfusion. 1987 Nov-Dec;27(6):478-81. doi: 10.1046/j.1537-2995.1987.27688071699.x. Transfusion. 1987. PMID: 2825381

3

Use of leukocyte-depleted platelets and cytomegalovirus-seronegative red blood cells for prevention of primary cytomegalovirus infection after marrow transplant.

Bowden RA, Slichter SJ, Sayers MH, Mori M, Cays MJ, Meyers JD. Bowden RA, et al. Among authors: sayers mh. Blood. 1991 Jul 1;78(1):246-50. Blood. 1991. PMID: 1648976 Free article. Clinical Trial.

4

The risk of transmitting cytomegalovirus infection by fresh frozen plasma.

Bowden R, Sayers M. Bowden R, et al. Among authors: sayers m. Transfusion. 1990 Oct;30(8):762-3. doi: 10.1046/j.1537-2995.1990.30891020340.x. Transfusion. 1990. PMID: 2171162

5

A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant.

Bowden RA, Slichter SJ, Sayers M, Weisdorf D, Cays M, Schoch G, Banaji M, Haake R, Welk K, Fisher L, McCullough J, Miller W. Bowden RA, et al. Among authors: sayers m. Blood. 1995 Nov 1;86(9):3598-603. Blood. 1995. PMID: 7579469 Free article. Clinical Trial.

6

Prevalence of human immunodeficiency virus type 1 p24 antigen in U.S. blood donors--an assessment of the efficacy of testing in donor screening. The HIV-Antigen Study Group.

Alter HJ, Epstein JS, Swenson SG, VanRaden MJ, Ward JW, Kaslow RA, Menitove JE, Klein HG, Sandler SG, Sayers MH, et al. Alter HJ, et al. Among authors: sayers mh. N Engl J Med. 1990 Nov 8;323(19):1312-7. doi: 10.1056/NEJM199011083231905. N Engl J Med. 1990. PMID: 2120589 Free article. Clinical Trial.

7

Reducing the risk for transfusion-transmitted cytomegalovirus infection.

Sayers MH, Anderson KC, Goodnough LT, Kurtz SR, Lane TA, Pisciotto P, Silberstein LE. Sayers MH, et al. Ann Intern Med. 1992 Jan 1;116(1):55-62. doi: 10.7326/0003-4819-116-1-55. Ann Intern Med. 1992. PMID: 1309201 Review.

8

Liberal or restrictive transfusion in high-risk patients after hip surgery.

Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR, Rhoads GG, Nemo G, Dragert K, Beaupre L, Hildebrand K, Macaulay W, Lewis C, Cook DR, Dobbin G, Zakriya KJ, Apple FS, Horney RA, Magaziner J; FOCUS Investigators. Carson JL, et al. N Engl J Med. 2011 Dec 29;365(26):2453-62. doi: 10.1056/NEJMoa1012452. Epub 2011 Dec 14. N Engl J Med. 2011. PMID: 22168590 Free PMC article. Clinical Trial.

9

Hepatitis C virus (HCV) infection in bone marrow transplant patients after transfusions from anti-HCV-positive blood donors.

Shuhart MC, Myerson D, Spurgeon CL, Bevan CA, Sayers MH, McDonald GB. Shuhart MC, et al. Among authors: sayers mh. Bone Marrow Transplant. 1996 Apr;17(4):601-6. Bone Marrow Transplant. 1996. PMID: 8722362

10

Red cell collection by apheresis technology.

Meyer D, Bolgiano DC, Sayers M, Price T, Benson D, Slichter SJ. Meyer D, et al. Among authors: sayers m. Transfusion. 1993 Oct;33(10):819-24. doi: 10.1046/j.1537-2995.1993.331094054618.x. Transfusion. 1993. PMID: 8236422

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

258 results

Search Page